BRIEF-Pfizer And Biontech Receive Positive CHMP Opinion For Lp.8.1-Adapted Covid-19 Vaccine In The European Union

Reuters
25 Jul
BRIEF-Pfizer And Biontech Receive Positive CHMP Opinion For Lp.8.1-Adapted Covid-19 Vaccine In The European Union

July 25 (Reuters) - BIONTECH SE 22UAy.DE:

  • PFIZER AND BIONTECH RECEIVE POSITIVE CHMP OPINION FOR LP.8.1-ADAPTED COVID-19 VACCINE IN THE EUROPEAN UNION

  • DOSES READY TO SHIP TO EU UPON EC AUTHORIZATION

  • CHMP RECOMMENDATION UNDER REVIEW BY EC, DECISION EXPECTED SOON

  • UPON AUTHORIZATION BY EUROPEAN COMMISSION $(EC)$, LP.8.1-ADAPTED COVID-19 VACCINE WILL BE AVAILABLE FOR INDIVIDUALS 6 MONTHS OF AGE AND OLDER

Source text: ID:nGNE1RGqxj

Further company coverage: [22UAy.DE]

(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10